Inventor
Joseph G. Reynolds
Inventor
North Andover, MA, US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
A61JContainers specially adapted for medical or pharmaceutical purposes8%
PatentTitleYear
9,913,901'Combination therapy for treating HER2-positive cancers'20189,610,249'Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents'20179,226,966'Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2018Patents assigned to MERRIMACK PHARMACEUTICALS INC (3)· patent assignee history
2016–2018Based in North Andover, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERRIMACK PHARMACEUTICALS INC | 3 | 2016–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| North Andover, Massachusetts, US | 3 | 2016–2018 |